Study reveals privacy risks in medical AI
AI models – for example, those used for cancer detection – are trained on patients’ health data. Even the mere fact that personal data has been incorporated into… read more.
AI models – for example, those used for cancer detection – are trained on patients’ health data. Even the mere fact that personal data has been incorporated into… read more.
AbbVie announced that the EC has approved SKYRIZI (risankizumab) for the treatment of children and adolescents six years of age and older with moderate to severe plaque psoriasis… read more.
There has been a lot of discussion about how the age at menopause can affect menopause symptoms. A new study compared the prevalence and severity of menopause symptoms… read more.
Older adults discharged from hospital with a new prescription for a sedative, especially a benzodiazepine or antipsychotic, are at increased risk of falls and other negative consequences, according… read more.
Novo Nordisk Pharma Co., Ltd. (Japan) announced an adaptation to the existing approval for its long-acting human growth hormone analog formulation “Sogrua” (generic name: Somapsitan (genetically modified)). The… read more.
The conditions that could help women GPs build long and rewarding careers already exist, but they are routinely undermined in everyday practice, according to a new review led… read more.
A novel economic model projects that patients with heart failure would live longer lives and spend less time in hospital by expanding heart failure care to include pharmacist-… read more.
Johnson & Johnson announced publication of the primary results from the MEMBRANE randomized controlled trial in JAMA Neurology. The study showed that adding middle meningeal artery embolization (MMAe)… read more.
Pre-retrieval imaging is moving liver transplantation toward a more precise and less invasive era. A new evidence synthesis shows how ultrasound, computed tomography, and magnetic resonance imaging can… read more.
This study is the first to analyse obesity trends from 2019 to 2025, using NHS England electronic health records covering nearly 55 million adults. The scale and detail… read more.
Gilead Sciences announced that the EC has granted marketing authorization for Trodelvy (sacituzumab govitecan-hziy) as monotherapy for the treatment of adult patients with unresectable or metastatic triple-negative breast… read more.
An international survey has highlighted major gaps in cardio-oncology training, despite its increasing clinical importance.1 These results were presented at ESC Cardio-Oncology 2026, the second annual conference of the European Society… read more.